Related Experiment Video
Updated: May 16, 2025
09:58
RhoC GTPase Activation Assay
Published on: August 22, 2010
12.4K
VAV2 Drives EGFR-Mediated Rac1 Responses in Prostate Cancer
Martin J Baker1, Suli Zhang2, Daniel Zhang3
1Manchester Cancer Research Centre (MCRC), Division of Cancer Sciences, University of Manchester, Manchester, United Kingdom.
Molecular Cancer Research : MCR
|April 4, 2025
Summary
The small G-protein Rac1 is crucial for prostate cancer progression. Targeting VAV2, a key regulator of Rac1, significantly impairs cancer cell growth and migration, suggesting VAV2 as a potential prognostic marker.
Area of Science:
- Oncology
- Molecular Biology
- Cell Signaling
Background:
- The small G-protein Rac1 is integral to cancer progression and metastasis.
- Rac1 acts as a signaling node for receptor tyrosine kinases, influencing cell motility, invasiveness, and gene expression.
- Rac1 is hyperactivated in aggressive prostate cancer models.
Purpose of the Study:
- To investigate the role of Rac1 and its regulators in prostate cancer.
- To identify key mediators of Rac1 activation in prostate cancer cells.
- To evaluate the prognostic significance of identified pathways in human prostate cancer.
Main Methods:
- CRISPR/Cas9-based knockout of Rac1 in prostate cancer cells.
- RNA interference (RNAi) screening of Rac1 Guanine nucleotide Exchange Factors (Rac-GEFs).
- Expression profiling, immunohistochemistry, and bioinformatic analysis of human prostate cancer biopsies.
Main Results:
- Rac1 knockout impaired prostate cancer cell proliferation and migration, altering transcriptional programs related to cell adhesion and ECM.
- VAV2 was identified as the primary mediator of epidermal growth factor (EGF)-induced Rac1 activation.
- VAV2 depletion reduced cancer cell proliferation and migration, and VAV2 overexpression correlated with poor clinical prognosis in human prostate cancer.
Conclusions:
- The VAV2-Rac1 pathway is a critical effector of EGFR-driven proliferation and migration in prostate cancer.
- VAV2 plays a central role in prostate cancer cell proliferation and migration.
- VAV2 holds potential as a prognostic biomarker for prostate cancer progression.
More Related Videos
Related Concept Videos
01:03Rous Sarcoma Virus (RSV) and Cancer
4.9K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
4.9K
02:38The Ras Gene
6.1K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
6.1K
01:24Small GTPases - Ras and Rho
3.8K
Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Three regulatory proteins control their activity:
3.8K
01:24Regulation of Angiogenesis and Blood Supply
2.5K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.5K
02:23Abnormal Proliferation
4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
01:07MAPK Signaling Cascades
5.0K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.0K